The 3rd GSDM International Symposium

January 12, 2016


Type Lecture
Intended for General public / Enrolled students / International students / Alumni / Companies / University students
Date(s) February 23, 2016 13:30 — 17:30
Location Hongo Area Campus
Venue Ito Hall, Ito International Research Center
Capacity 300 people
Entrance Fee No charge
Registration Method Advance registration required

 Today, the movement of people and goods has increased dramatically. As was highlighted by a number of cases such as the rapid spread of the Ebola outbreak in West Africa or the emergence of new influenza viruses, there exists a wide gap between research and on-site applications in the medical field. Furthermore, such cases also showed the necessity of building an effective and strong risk management system including research and development within global health governance. In addition, societal change including demographic decline and aging population increases the need for new medical technologies and systems based on new values, such as regenerative medicine and personalized medicine.
 In the symposium, keeping such issues in mind, we would like to provide a platform for discussing three dimensions of medical health innovation from a global perspective: an overview of the latest issues of research and development, the process of on-site application of research results, and the role of each actor including research institutions, private companies, governments and international organizations. The symposium aims at searching for ways to fill the above-mentioned gap between research and on-site application, as well as the cooperation among the public sector, private sector, and universities for the improvement of global governance.
 In addition, we would like to consider the education of future distinguished young researchers and practitioners in this field. What kinds of elements are necessary to train someone capable of developing research but at the same time of applying the research results to the various healthcare settings, responding to on-site demands, and cooperating with a variety of actors? We would like to discuss such topics with panelists from various sectors including GSDM students.

*Simultaneous interpretation will be provided.


13:00- Registration
13:30-13:40 Opening remarks
Professor Hiroyuki Yamato
GSDM Program Director, Executive Vice President of the University of Tokyo
13:40-14:10 Crosscutting speeches: Global public health and medical innovation
Professor Hideaki Shiroyama, GSDM Program Coordinator, Dean of the Graduate School of Public Policy, the University of Tokyo
Professor Vish Krishnan, Rady School of Management, University of California, San Diego
14:10-14:20 Q&A
14:20-15:40 Session 1 “Global Health Governance”
In order to set in place a robust risk management system in the medical and health field, there are three main issues that require consideration: (1) the promotion of investment into research institutions and pharmaceutical companies, (2) the realistic funding and risk management including the improvement of insurance, and (3) the issue of global governance by international organizations, private entities and governments. In this session, experts from international organizations, the Government of Japan, and the private sector are invited to discuss how global health governance and risk management frameworks, including research and development mechanisms, should be developed with the cooperation of various actors.
Professor Kenji Shibuya, Graduate School of Medicine, the University of Tokyo
– Dr. Tadataka Yamada, Venture Partner, Frazier Healthcare Partners
– Mr. Tetsuo Yoshioka, Councillor of the Cabinet Secretariat, Director General of Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Office for Ebola Virus Disease Preparedness and Response, and Coordination Office of Measures on Emerging Infectious Diseases
– BT Slingsby, CEO and Executive Director, Global Health Innovative Technology (GHIT) Fund
– Mr. Atsuyuki Oike, Ambassador, Assistant Vice-Minister / Director-General for Global Issues, Ministry of Foreign Affairs


15:40-15:55 Break time
15:55-17:15 Session 2 “Biomedical Innovation”
To fill the gap existing between research and on-site applications, the presence of a “mediator” is necessary – who can engage in research from a global perspective, responding to demands from clinical on-site practice, and applying research results in various clinical fields. In this session, medical researchers and practitioners will discuss possible ways to apply research results to innovation responding to immediate demand.
Professor Hiroshi Suzuki, Graduate School of Public Policy, the University of Tokyo
– Professor Vish Krishnan
– Sompo Japan Nipponkoa Holdings, Inc.
– Mr. Keita Mori, Co-CEO, Chairman, Co-Founder, SanBio, Inc.
– Professor Mamoru Mitsuishi, GSDM Deputy Program Coordinator, Dean of the Graduate School of Engineering, the University of Tokyo
17:15-17:30 Closing remarks
Professor Hideaki Shiroyama

Related links

Access Map
Kashiwa Campus
Hongo Campus
Komaba Campus